ANIX

Anixa Biosciences Inc

Jun 12 • 04:00PM ET

2.47

-0.01 -0.40 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ATYR COYA CYPH INO LONA NRXS CGTX KLRS NRXP KALA

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.30	Insider Own	5.38%	Shs Outstand	33.92M	Perf Week	-0.40%
Market Cap	84.04M	Forward P/E	-	EPS next Y	-0.35	Insider Trans	0.55%	Shs Float	32.19M	Perf Month	-14.83%
Enterprise Value	69.28M	PEG	-	EPS next Q	-0.09	Inst Own	14.97%	Short Float	3.15%	Perf Quarter	-12.72%
Income	-10.03M	P/S	-	EPS this Y	1.47%	Inst Trans	-2.95%	Short Ratio	9.13	Perf Half Y	-51.85%
Sales	0.00M	P/B	5.79	EPS next Y	-4.48%	ROA	-63.02%	Short Interest	1.01M	Perf YTD	-20.83%
Book/sh	0.43	P/C	6.14	EPS next 5Y	-3.32%	ROE	-65.70%	52W High	5.46 -54.73%	Perf Year	-31.39%
Cash/sh	0.40	P/FCF	-	EPS past 3/5Y	9.05% 5.67%	ROIC	-68.66%	52W Low	2.32 6.47%	Perf 3Y	-26.71%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.16% 5.49%	Perf 5Y	-42.15%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	19.64%	Oper. Margin	-	ATR (14)	0.15	Perf 10Y	-25.60%
Dividend Ex-Date	-	Quick Ratio	9.79	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	39.33	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	9.79	EPS Q/Q	13.51%	SMA20	-5.60%	Beta	0.62	Target Price	11.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-11.58%	Rel Volume	1.31	Prev Close	2.48
Employees	4	LT Debt/Eq	0.01	Earnings	Mar 13	SMA200	-25.37%	Avg Volume	111.04K	Price	2.47
IPO	Oct 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.21% -	Trades		Volume	145,801	Change	-0.40%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)